Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses In Vivo

de Oca, RM (author)

Alavi, AS (author)

Vitali, N (author)

show more...

Bhattacharya, S (author)

Blackwell, C (author)

Patel, K (author)

Seestaller-Wehr, L (author)

Kaczynski, H (author)

Shi, H (author)

Dobrzynski, E (author)

Obert, L (author)

Tsvetkov, L (author)

Cooper, DC (author)

Jackson, H (author)

Bojczuk, P (author)

Forveille, S (author)

Kepp, O (author)

Sauvat, A (author)

Kroemer, G (author)

Creighton-Gutteridge, M (author)

Yang, JS (author)

Hopson, C (author)

Yanamandra, N (author)

Shelton, C (author)

Mayes, P (author)

Opalinska, J (author)

Barnette, M (author)

Srinivasan, R (author)

Smothers, J (author)

Hoos, A (author)

show less...

2021

2021

English.

In: Molecular cancer therapeutics. - 1538-8514. ; 20:10, s. 1941-1955

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)